Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2005 Dec;97(12):1725–1728.

Trimethoprim-sulfamethoxazole-induced aseptic meningitis.

Charles Wambulwa 1, Salome Bwayo 1, Adeyinka O Laiyemo 1, Fredric Lombardo 1
PMCID: PMC2640752  PMID: 16396068

Abstract

We present a 46-year-old African-American man with AIDS who was admitted on two different occasions within three weeks for signs and symptoms of meningitis after using trimethoprim/sulfamethoxazole (TMP/SMX). TMP/SMX is primarily used for the treatment of pneumocystis carinii pneumonia prophylaxis in AIDS patients. Drug-induced aseptic meningitis (DIAM) is commonly seen with nonsteroidal anti-inflammatory drugs (NSAIDS), antibiotics (with TMP/SMX being the most frequently implicated), intravenous immunoglobulins and OKT3 antibodies. However, the implication of TMP/SMX inducing aseptic meningitis has been underreported to FDA/MEDWATCH program. This might be due to the fact that it has also been used to treat bacterial meningitis from organisms like Listeria monocytogenes, which is a common pathogen in the elderly and in infants. We reviewed the literature in an attempt to characterize the pattern and predictors of TMP/SMX-induced aseptic meningitis.

Full text

PDF
1725

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antonen J., Hulkkonen J., Pasternack A., Hurme M. Interleukin 6 may be an important mediator of trimethoprim-induced systemic adverse reaction resembling aseptic meningitis. Arch Intern Med. 2000 Jul 10;160(13):2066–2067. [PubMed] [Google Scholar]
  2. Beutler B. TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med. 1995 Jun;43(3):227–235. [PubMed] [Google Scholar]
  3. Carlson J., Wiholm B. E. Trimethoprim associated aseptic meningitis. Scand J Infect Dis. 1987;19(6):687–691. doi: 10.3109/00365548709117205. [DOI] [PubMed] [Google Scholar]
  4. Dinarello C. A. Biologic basis for interleukin-1 in disease. Blood. 1996 Mar 15;87(6):2095–2147. [PubMed] [Google Scholar]
  5. Floris-Moore Michelle A., Amodio-Groton Maria I., Catalano Michela T. Adverse reactions to trimethoprim/sulfamethoxazole in AIDS. Ann Pharmacother. 2003 Dec;37(12):1810–1813. doi: 10.1345/aph.1D179. [DOI] [PubMed] [Google Scholar]
  6. Harrison M. S., Simonte S. J., Kauffman C. A. Trimethoprim-induced aseptic meningitis in a patient with AIDS: case report and review. Clin Infect Dis. 1994 Sep;19(3):431–434. doi: 10.1093/clinids/19.3.431. [DOI] [PubMed] [Google Scholar]
  7. Hopkins Susan, Jolles Stephen. Drug-induced aseptic meningitis. Expert Opin Drug Saf. 2005 Mar;4(2):285–297. doi: 10.1517/14740338.4.2.285. [DOI] [PubMed] [Google Scholar]
  8. Joffe A. M., Farley J. D., Linden D., Goldsand G. Trimethoprim-sulfamethoxazole-associated aseptic meningitis: case reports and review of the literature. Am J Med. 1989 Sep;87(3):332–338. doi: 10.1016/s0002-9343(89)80160-3. [DOI] [PubMed] [Google Scholar]
  9. Jurado R., Carpenter S. L., Rimland D. Case reports: trimethoprim-sulfamethoxazole-induced meningitis in patients with HIV infection. Am J Med Sci. 1996 Jul;312(1):27–29. doi: 10.1097/00000441-199607000-00005. [DOI] [PubMed] [Google Scholar]
  10. Koirala Janak. Trimethoprim-sulfamethoxazole--induced methemoglobinemia in an HIV-infected patient. Mayo Clin Proc. 2004 Jun;79(6):829–830. doi: 10.4065/79.6.829-a. [DOI] [PubMed] [Google Scholar]
  11. Patterson R. G., Couchenour R. L. Trimethoprim-sulfamethoxazole-induced tremor in an immunocompetent patients. Pharmacotherapy. 1999 Dec;19(12):1456–1458. doi: 10.1592/phco.19.18.1456.30903. [DOI] [PubMed] [Google Scholar]
  12. Rudy B. J., Rutstein R. Aseptic meningitis from trimethoprim-sulfamethoxazole in an HIV-infected adolescent. Pediatr Emerg Care. 1997 Jun;13(3):216–217. doi: 10.1097/00006565-199706000-00010. [DOI] [PubMed] [Google Scholar]
  13. Slavik R. S., Rybak M. J., Lerner S. A. Trimethoprim/sulfamethoxazole-induced tremor in a patient with AIDS. Ann Pharmacother. 1998 Feb;32(2):189–192. doi: 10.1345/aph.17173. [DOI] [PubMed] [Google Scholar]
  14. Therrien Roxane. Possible trimethoprim/sulfamethoxazole-induced aseptic meningitis. Ann Pharmacother. 2004 Sep 14;38(11):1863–1867. doi: 10.1345/aph.1D581. [DOI] [PubMed] [Google Scholar]
  15. Trepanier Lauren A., Danhof Rebecca, Toll Jeffrey, Watrous Deborah. Clinical findings in 40 dogs with hypersensitivity associated with administration of potentiated sulfonamides. J Vet Intern Med. 2003 Sep-Oct;17(5):647–652. doi: 10.1111/j.1939-1676.2003.tb02495.x. [DOI] [PubMed] [Google Scholar]
  16. Tunkel A. R., Starr K. Trimethoprim-sulfamethoxazole-associated aseptic meningitis. Am J Med. 1990 Jun;88(6):696–697. doi: 10.1016/0002-9343(90)90546-p. [DOI] [PubMed] [Google Scholar]
  17. Wong J. G., Hathaway S. C., Paat J. J., Paterson R. W., Steele G. H., Jr Drug-induced meningitis. A case involving trimethoprim-sulfamethoxazole. Postgrad Med. 1994 Nov 1;96(6):117-8, 121,124. [PubMed] [Google Scholar]
  18. Worthington Michael G., Ross John J. Aseptic meningitis and acute HIV syndrome after interruption of antiretroviral therapy: implications for structured treatment interruptions. AIDS. 2003 Sep 26;17(14):2145–2146. doi: 10.1097/00002030-200309260-00026. [DOI] [PubMed] [Google Scholar]
  19. de la Monte S. M., Hutchins G. M., Gupta P. K. Aseptic meningitis, trimethoprim, and Sjögren's syndrome. JAMA. 1985 Apr 19;253(15):2192–2192. doi: 10.1001/jama.253.15.2192c. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES